SPG11 and Cognitive impairment: 70% of complex HSP patients presenting with progressive spasticity, intellectual impairment and thin corpus callosum are accounted for by mutations in SPG11/spatacsin and ZFYVE26/spastizin [6], both having roles in autophagosome maturation and endolysosomal function [57].